Methods and compositions for treatment of cancer using oncolytic RSV activity
US9241998B2 · kind B2 · utility
2Cited by
13References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2008 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Nov 27, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18532
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to methods and compositions employing the oncolytic activity of respiratory syncytial virus (RSV) to treat cancer and other neoplastic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.